Product Name: Human CD28L / CD80 Antibody (Galiximab, Research Use)
Catalog Number: NBR-0561
Target Name: CD28L / CD80
Trade Name: Galiximab
Antibody Drug Description: Galiximab is a monoclonal antibody that is being studied in the treatment of follicular non-Hodgkin lymphoma.  Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD80
Synonyms: B7-1; B7.1; CD28LG; CD28LG1
Target Description: Involved in the costimulatory signal essential for T-lymphocyte activation. T-cell proliferation and cytokine production is induced by the binding of CD28, binding to CTLA-4 has opposite effects and inhibits T-cell activation.
Ensembl: ENSG00000121594
Uniprot: P33681